Latest news
Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment
Nucleai and Altis Labs are transforming clinical trials through AI innovation
Nucleai announces strategic collaboration with Mayo Clinic BioPharma Diagnostics
Nucleai and Adlai Nortye Partner to Identify and Validate Novel Spatial Biomarkers Across Adlai Clinical Trials
Nucleai closes $33 Million Series B financing to advance its spatial biology platform for drug research, Development and diagnostics
Nucleai and Jefferson Health Launch a Strategic Collaboration to discover novel Biomarkers
Nucleai Partners With Sheba Medical Center’s ARC Innovation Center For a New Strategic Data Collaboration
Debiopharm invests in NucleAI– using AI to develop digital pathology biomarkers